Virginie Jakob

Rue Du Champ Blanchot 4
Plan, GR 1228, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.

Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.

Journal: Vaccine

Published: October 03, 2025

Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice.

Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice.

Journal: Pharmaceutics

Published: October 25, 2023

Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants.

Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants.

Journal: NPJ vaccines

Published: April 16, 2023

Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine.

Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine.

Journal: Frontiers in immunology

Published: June 24, 2022

Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Journal: NPJ vaccines

Published: January 06, 2022

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Journal: NPJ vaccines

Published: March 02, 2021

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration.

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration.

Journal: Vaccines

Published: January 07, 2021

Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae.

Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae.

Journal: Veterinary research

Published: June 14, 2019

A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.

A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.

Journal: Viruses

Published: May 20, 2019

Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.

Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 06, 2019

Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Journal: Frontiers in immunology

Published: January 08, 2019

Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis.

Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis.

Journal: Therapeutic advances in vaccines

Published: July 11, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026